We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.04T
AUM Growth
–
Cap. Flow
+$4.22T
Cap. Flow
% of AUM
104.32%
Top 10 Holdings %
Top 10 Hldgs %
32.57%
Holding
4,062
New
4,062
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$282B |
| 2 |
Apple
AAPL
|
+$248B |
| 3 |
Microsoft
MSFT
|
+$202B |
| 4 |
Amazon
AMZN
|
+$139B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$119B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.5% |
| 2 | Financials | 12.85% |
| 3 | Healthcare | 9.93% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CON
1426
Concentra Group Holdings
CON
$4.43B
| $109M | ﹤0.01% |
+5,095,516
| New | +$113M |
|
1427
Banc of California
BANC
$3B
| $109M | ﹤0.01% |
+6,196,123
| New | +$118M |
|
1428
Visteon
VC
$2.83B
| $109M | ﹤0.01% |
+1,195,376
| New | +$113M |
|
|
DX
1429
Dynex Capital
DX
$3.31B
| $109M | ﹤0.01% |
+8,513,684
| New | +$117M |
|
|
BGSI
1430
Boyd Group Services
BGSI
$2.63B
| $108M | ﹤0.01% |
+849,434
| New | +$137M |
|
1431
Summit Therapeutics
SMMT
$10.5B
| $108M | ﹤0.01% |
+5,711,802
| New | +$92.4M |
|
1432
Mercury Insurance
MCY
$5.78B
| $108M | ﹤0.01% |
+1,226,459
| New | +$110M |
|
1433
Tango Therapeutics
TNGX
$4.25B
| $108M | ﹤0.01% |
+5,161,431
| New | +$71.8M |
|
1434
Vera Therapeutics
VERA
$2.33B
| $108M | ﹤0.01% |
+2,683,607
| New | +$116M |
|
1435
RXO
RXO
$3.66B
| $108M | ﹤0.01% |
+7,370,484
| New | +$108M |
|
1436
WaFd
WAFD
$2.72B
| $108M | ﹤0.01% |
+3,427,275
| New | +$110M |
|
1437
Trustmark
TRMK
$2.7B
| $107M | ﹤0.01% |
+2,545,422
| New | +$107M |
|
1438
ICL Group
ICL
$7.1B
| $107M | ﹤0.01% |
+20,676,694
| New | +$111M |
|
1439
Hilton Grand Vacations
HGV
$3.52B
| $106M | ﹤0.01% |
+2,717,289
| New | +$122M |
|
1440
Avis
CAR
$5B
| $106M | ﹤0.01% |
+726,942
| New | +$82.9M |
|
1441
BioCryst Pharmaceuticals
BCRX
$2.57B
| $106M | ﹤0.01% |
+11,135,762
| New | +$86.5M |
|
1442
First Merchants
FRME
$2.64B
| $106M | ﹤0.01% |
+2,730,611
| New | +$107M |
|
1443
Loar Holdings
LOAR
$7.17B
| $105M | ﹤0.01% |
+1,824,449
| New | +$123M |
|
1444
Dentsply Sirona
XRAY
$2.2B
| $104M | ﹤0.01% |
+8,999,557
| New | +$112M |
|
1445
Highwoods Properties
HIW
$3.45B
| $104M | ﹤0.01% |
+4,875,391
| New | +$117M |
|
1446
Howard Hughes
HHH
$4.07B
| $104M | ﹤0.01% |
+1,649,652
| New | +$124M |
|
1447
Beam Therapeutics
BEAM
$3B
| $104M | ﹤0.01% |
+4,377,374
| New | +$121M |
|
|
ARIS
1448
Aris Mining
ARIS
$4.05B
| $104M | ﹤0.01% |
+5,589,237
| New | +$106M |
|
1449
Madison Square Garden
MSGE
$3.9B
| $104M | ﹤0.01% |
+1,760,512
| New | +$104M |
|
1450
InvenTrust Properties
IVT
$2.6B
| $104M | ﹤0.01% |
+3,400,538
| New | +$102M |
|
Similar funds
Vanguard Capital Management's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Capital Management, which disclosed 4,062 positions worth $4.04T. Its ten largest holdings account for 33% of the portfolio.
Its largest position is NVIDIA: 1,538,550,382 shares worth $268B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, followed by Financials and Healthcare.
- Vanguard Capital Management's largest Q1 2026 buy was NVIDIA: 1,538,550,382 shares worth $268B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.04T portfolio in Q1 2026.
- Vanguard Capital Management disclosed 4,062 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.